Identification of key genes as potential diagnostic and therapeutic targets for comorbidity of myasthenia gravis and COVID-19
Description
INTRODUCTION: Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder. Coronavirus disease 2019 (COVID-19) has a significant impact on the health and quality of life of MG patients and may even trigger the onset of MG in some cases